Background and Design: A controlled trial was undertaken from December
1987 to December 1990 to test the hypothesis that a strong sunscreen
can reduce the number of cancerous and precancerous skin lesions. Cand
idates were selected from a high-risk population attending either a un
iversity- or Veterans Affairs-based dermatology practice in Lubbock, T
ex, for a prospective, double-blind, controlled trial of daily applica
tion of sunscreen vs placebo over a 2-year period. Participants were a
sked to volunteer if they had demonstrated premalignant changes (actin
ic keratoses) or nonmelanoma skin cancer (basal cell carcinoma or squa
mous cell carcinoma), had continuing sun exposure, and were not using
sunscreen on a regular basis. Fifty-three volunteers were initially en
rolled in the study, and 37 came for the final 24-month visit. Results
: The rate of appearance of new precancerous skin lesions was less for
the treatment group than for control subjects. People with darker ski
n had fewer actinic keratoses, women had fewer lesions than men, and p
eople with fewer lesions at enrollment had fewer lesions during the st
udy. The numbers of new nonmelanoma skin cancers appearing during the
study period were too small for statistical analysis. Conclusions: The
regular use of sunscreens can significantly reduce cutaneous neoplasi
a, as indicated by its suppression of precancerous lesions. A longer a
nd/or larger study would be necessary to demonstrate an effect on mali
gnant lesions.